PDS appoints Graham Clapperton
pharmafile | January 22, 2010 | Appointment | Research and Development | PDS, appointment, research and development
Pharmaceutical Development Services Ltd (PDS) has appointed Graham Clapperton to head up its quality services.
Graham joins the Nottingham, UK-based consultancy as associate director with responsibility for quality and compliance services.
Graham has 35 years experience in pharmaceutical quality management at industry giant 3M, where for the last twelve years he served as European quality manager.
Michael Gamlen, managing director at PDS, said: “As PDS consultancy and training activities continue to expand at an accelerating pace, it is important that we build a team which is capable of continuing to provide the high level of expertise that our clients have come to expect.
“We make a point of continually monitoring the top people in our areas of expertise, adding them to our team if they become available.”
Related Content
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
Lonza CEO to step down in 2020
It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …